IDEXX Raises Outlook After Beating Estimates
IDEXX Laboratories raised its annual profit and revenue forecast after beating quarterly estimates. The company is benefiting from rising diagnostic use per visit despite weaker clinic traffic. Shares of the pet diagnostics maker climbed following the announcement.
Xurve View
Insights:
Xurve View
IDEXX Laboratories Inc raised its full-year profit and revenue outlook after posting third-quarter results that beat Wall Street estimates on Monday morning. Shares of the animal-health diagnostic company jumped 19% in morning trading following the announcement. The upward revision relies on increased diagnostic testing per clinic visit to offset softer pet owner traffic.
